Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current pharmaceutical design

• Publication date

  2002-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1381612023394917PMID 11945151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative rectal diclofenac versus paracetamol for tonsillectomy: effects on pain and blood loss

  2001cited by this paper
• Coexpression of Microsomal-Type Prostaglandin E Synthase with Cyclooxygenase-2 in Brain Endothelial Cells of Rats during Endotoxin-Induced Fever

  2001cited by this paper
• Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.

  2001cited by this paper
• Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.

  2001cited by this paper
• Cyclooxygenase 2 inhibitors and thrombogenicity production: comment on the article by Crofford et al.

  2001cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.

  2001cited by this paper
• Celecoxib versus diclofenac in the management of osteoarthritis of the knee.

  2001cited by this paper
• Pyrogenic cytokines injected into the rat cerebral ventricle induce cyclooxygenase‐2 in brain endothelial cells and also upregulate their receptors

  2001cited by this paper
• Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis*

  2001cited by this paper
• Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group.

  2000cited by this paper
• Are selective COX-2 inhibitors nephrotoxic?

  2000cited by this paper
• Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.

  2000cited by this paper
• Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases.

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Platelet dysfunction after intravenous ketorolac or propacetamol

  2000cited by this paper
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.

  2000cited by this paper
• Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.

  2000cited by this paper
• Effects of celecoxib and naproxen on renal function in the elderly.

  2000cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib

  2000cited by this paper
• Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

  2000cited by this paper
• Inhibition of Noxious Stimulus‐Induced Spinal Prostaglandin E2 Release by Flurbiprofen Enantiomers

  2000cited by this paper
• Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.

  2000cited by this paper
• Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

  2000cited by this paper
• Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs.

  2000cited by this paper
• Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects

  1999cited by this paper
• Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.

  1999cited by this paper
• Cyclooxygenase‐2 inhibition by rofecoxib reverses naturally occurring fever in humans

  1999cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.

  1999cited by this paper
• Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs.

  1999cited by this paper
• Immunolocalization of cyclooxygenase‐2 in the macula densa of human elderly

  1999cited by this paper
• Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

  1999cited by this paper
• Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation.

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.

  1999cited by this paper
• Characterization of rofecoxib as a cyclooxygenase‐2 isoform inhibitor and demonstration of analgesia in the dental pain model

  1999cited by this paper
• Effects of acetaminophen and ibuprofen on renal function in the stressed kidney.

  1999cited by this paper
• Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

  1999cited by this paper
• Pharmacological analysis of cyclooxygenase-1 in inflammation.

  1998cited by this paper
• Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide.

  1998cited by this paper
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.

  1998cited by this paper
• Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity

  1998cited by this paper
• Effect of over-the-counter dosages of naproxen sodium and acetaminophen on plasma lithium concentrations in normal volunteers.

  1998cited by this paper
• Non-steroidal anti-inflammatory agents in patients with a renal transplant.

  1998cited by this paper
• Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.

  1998cited by this paper
• Paracetamol with and without codeine in acute pain: a quantitative systematic review

  1997cited by this paper
• The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency.

  1997cited by this paper
• Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

  1997cited by this paper
• Acetaminophen‐Related Acute Renal Failure without Fulminant Liver Failure

  1997cited by this paper
• Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.

  1996cited by this paper
• Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin.

  1996cited by this paper
• Acetaminophen: acute and chronic effects on renal function.

  1996cited by this paper
• Acute renal failure due to acetaminophen ingestion: a case report and review of the literature.

  1995cited by this paper
• Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis

  1994cited by this paper
• Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: Evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency

  1994cited by this paper
• Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.

  1992cited by this paper
• The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers.

  1990cited by this paper
• Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison.

  1990cited by this paper
• Acute effects of paracetamol on prostaglandin synthesis and renal function in normal man and in patients with renal failure.

  1990cited by this paper
• Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol).

  1989cited by this paper
• Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma.

  1988cited by this paper
• Effects of paracetamol and acetylsalicylic acid on the post-operative course after experimental orthopaedic surgery in dogs.

  1988cited by this paper
• The clinical significance of inhibition of renal prostaglandin synthesis.

  1987cited by this paper
• Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.

  1987cited by this paper
• Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake.

  1985cited by this paper
• Anti-inflammatory and antiarthritic evaluation of acetaminophen and its potentiation of tolmetin.

  1983cited by this paper
• Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance.

  1981cited by this paper
• Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney.

  1981cited by this paper
• Prostaglandin synthesis and renal function in man.

  1980cited by this paper
• Analgesic and anti-inflammatory effects of paracetamol evaluated by bilateral oral surgery.

  1980cited by this paper
• Evidence for an extra-renal origin of urinary prostaglandin E2 in healthy men.

  1979cited by this paper
• The effect of 4-acetamidophenol on prostaglandin synthetase activity in bovine and ram seminal vesicle microsomes.

  1978cited by this paper
• Gas chromatographic determination of hydrocodone in serum.

  1977cited by this paper
• Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents.

  1976cited by this paper
• ON THE ABILITY OF PROSTAGLANDIN E1 AND ARACHIDONIC ACID TO MODULATE EXPERIMENTALLY INDUCED OEDEMA IN THE RAT PAW

  1975cited by this paper
• Quantitation of thermography in arthritis using multi-isothermal analysis. II. Effect of nonsteroidal anti-inflammatory therapy on the thermographic index.

  1974cited by this paper
• Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

  1967cited by this paper
• SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN.

  1964cited by this paper

• Pharmacokinetic and Pharmacodynamic Characteristics of Pelubiprofen Tromethamine vs. Pelubiprofen in Healthy Subjects

  2023cites this paper
• Comparative Study of Intravenous Flurbiprofen and Acetaminophen for Preventing Pain after Third Molar Surgery: A Retrospective Cohort Study

  2023cites this paper
• The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses

  2023cites this paper
• An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact

  2023cites this paper
• Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older

  2022cites this paper
• Postoperative pain relief in pediatric surgery patients: Effect of intravenous paracetamol in comparison with diclofenac suppository

  2022cites this paper
• Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action

  2021cites this paper
• Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?

  2021cites this paper
• Pain Management Strategies Following Anterior Cruciate Ligament Reconstruction - A Systematic Review with Network Meta-Analysis.

  2021cites this paper
• Paracetamol versus placebo for knee and hip osteoarthritis.

  2019cites this paper
• Optimizing Outcomes in Urologic Surgery: Intraoperative Considerations

  2018cites this paper
• Is celecoxib a useful adjunct in the treatment of post-tonsillectomy pain in the adult population? A randomised, double-blind, placebo-controlled study

  2017cites this paper
• Practical recipes from start (preop) to finish (post-discharge)

  2015cites this paper
• Pain management in emergency department: intravenous morphine vs. intravenous acetaminophen

  2015cites this paper
• Clinical Study The Effects of Bariatric SurgeryWeight Loss on Knee Pain in Patients with Osteoarthritis of the Knee

  2014cites this paper
• Preemptive, Preventive, Multimodal Analgesia: What Do They Really Mean?

  2014cites this paper
• Cardiovascular Effects of Common Analgesics

  2013cites this paper
• Cardiovascular effects of common analgesics.

  2013cites this paper
• Implication des canaux Cav3.2 dans l'effet antalgique du paracétamol et dans la douleur inflammatoire

  2013cites this paper
• Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain

  2012cites this paper
• IV Acetaminophen Improves Pain Management and Reduces Opioid Requirements in Surgical Patients

  2012cites this paper
• DIAGNÓSTICO E ABORDAGEM TERAPÊUTICA DA OSTEOARTRITE

  2012cites this paper
• The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients with Osteoarthritis of the Knee

  2012cites this paper
• Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.

  2010cites this paper
• AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.

  2010cites this paper
• Vitamin C suppresses proliferation of the human melanoma cell SK‐MEL‐2 through the inhibition of cyclooxygenase‐2 (COX‐2) expression and the modulation of insulin‐like growth factor II (IGF‐II) production

  2008cites this paper
• Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.

  2007cites this paper
• Acetaminophen, Phenacetin and Dipyrone Do Not Modulate Pressor Responses to Arachidonic Acid or to Pressor Agents

  2007cites this paper
• A structured literature review of pain assessment and management of patients with chronic kidney disease.

  2007cites this paper
• Multimodal analgesia techniques and postoperative rehabilitation.

  2005cites this paper
• Tolerability of Paracetamol

  2005cites this paper
• Multimodal analgesia techniques for ambulatory surgery.

  2005cites this paper
• The Role of Paracetamol in Chronic Pain: An Evidence-Based Approach

  2005cites this paper
• Introduction — The coxib controversies

  2005cites this paper
• Section E: Useful Adjuncts in Ambulatory Anesthesia, Which Includes Regional Anesthesia Multimodal Analgesia Techniques for Ambulatory Surgery

  2005cites this paper
• Valdecoxib for the management of chronic and acute pain

  2005cites this paper
• Paracetamol in osteoarthritis of the knee

  2004cites this paper
• Peripherally restricted opioid agonists as novel analgesic agents.

  2004cites this paper
• Cardiovascular and renovascular implications of COX-2 inhibition.

  2004cites this paper
• Clinical Use of Non-Steroidal Anti-Inflammatory Drugs

  2004cites this paper
• Induction of Microsomal Prostaglandin E Synthase-1 in Human Gingival Fibroblasts

  2004cites this paper
• Antiretroviral drugs and the kidney: dosage adjustment and renal tolerance.

  2004cites this paper
• Clinical pharmacology of novel selective COX-2 inhibitors.

  2004cites this paper
• PET imaging of opioid receptors in pain: progress and new directions.

  2004cites this paper
• Pain treatment: a historical overview.

  2004cites this paper
• Adjunctive therapy for percutaneous revascularization in acute myocardial infarction.

  2004cites this paper
• Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia.

  2003cites this paper
• Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor

  2003cites this paper
• Gastroduodenal safety of cyclooxygenase-2 inhibitors.

  2003cites this paper
• COX-2 and colorectal cancer.

  2003cites this paper
• Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction.

  2003cites this paper
• Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.

  2003cites this paper
• [Tolerability of paracetamol].

  2003cites this paper
• Acute Pain Management

  2003cites this paper
• Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects

  2003cites this paper